EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic value of receptor status change following neoadjuvant chemotherapy in locally advanced breast cancer

Vahit Ozmen, Ajlan Atasoy, Atilla Bozdogan, Maktav Dincer, Yesim Eralp, Sitki Tuzlali

Cancer Treatment Communications · 2015 · 4 · 89-95

DOI: 10.1016/j.ctrc.2015.07.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment Communications, 2015. Verfasst von Vahit Ozmen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effect of neoadjuvant chemotherapy (NAC) on the expression of receptor status in locally advanced breast cancer (LABC) is still under investigation. Aims of this study are to evaluate changes in hormone receptor (HR) and HER-2 status post-NAC and correlation with survival. LABC patients who received NAC between 2001 and 2008 at Istanbul University were analyzed retrospectively. Patients with pathologic complete response (pCR) were excluded in analysis. Immunohistochemical (IHC) analyses was performed on both initial biopsies and surgical specimens. The median age of 128 patients was 48 years and 55% of them were premenopausal. Most of the patients had invasive ductal (81%) and histologic grade (HG) III (81%) breast cancer. Partial pathologic response (pPR) rate was 86.7%. HR status changed in 36 patients (28%). The rates of ER, PR and HER-2 receptor positivity at diagnosis and after NAC were 44–32.8%, 43–29.7%, and 24–21%, respectively. Negative-to-positive change in HR status was observed in five patients. The 5-year overall survival (OS) was 76% in patients whose HR status converted to negative, compared with 91% in patients who remained HR-positive (p

Zitieren

APA

Ozmen, V., Atasoy, A., Bozdogan, A., Dincer, M., Eralp, Y., & Tuzlali, S. (2015). Prognostic value of receptor status change following neoadjuvant chemotherapy in locally advanced breast cancer. Cancer Treatment Communications, 4, 89-95. https://doi.org/10.1016/j.ctrc.2015.07.001

Vancouver

Ozmen V, Atasoy A, Bozdogan A, Dincer M, Eralp Y, Tuzlali S. Prognostic value of receptor status change following neoadjuvant chemotherapy in locally advanced breast cancer. Cancer Treatment Communications. 2015;4:89-95. doi:10.1016/j.ctrc.2015.07.001

BibTeX
@article{Ozmen2015,
  author = {Ozmen, Vahit and Atasoy, Ajlan and Bozdogan, Atilla and Dincer, Maktav and Eralp, Yesim and Tuzlali, Sitki},
  title = {Prognostic value of receptor status change following neoadjuvant chemotherapy in locally advanced breast cancer},
  journal = {Cancer Treatment Communications},
  year = {2015},
  volume = {4},
  pages = {89--95},
  doi = {10.1016/j.ctrc.2015.07.001}
}
Kostenlos starten →